Pyridazinone derivatives

Details for Australian Patent Application No. 2009331991 (hide)

Owner MERCK PATENT GMBH

Inventors Stieber, Frank; Schadt, Oliver; Dorsch, Dieter; Blaukat, Andree

Agent Griffith Hack

Pub. Number AU-A-2009331991

PCT Pub. Number WO2010/072296

Priority 10 2008 062 826.3 23.12.08 DE

Filing date 24 November 2009

Wipo publication date 1 July 2010

International Classifications

C07D 403/08 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/072296 Priority application(s): WO2010/072296

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331996-3-(3-pyrimidine-2-yl-benzyl)-[1,2,4] triazolo [4,3-b] pyridazine derivatives

2009331990-Novel polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5- (2-morpholin-4-yl-ethoxy)-pyrimidin2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof